A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment

被引：4
|
作者：
Lee, Chooi Yeng [1 ]
机构：
[1] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia
来源：
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词：
combination therapy; diet; glucagon-like peptide-1 agonist; gut-brain axis; obesity; LAPAROSCOPIC SLEEVE GASTRECTOMY; WEIGHT-LOSS; GLUCOSE-INTOLERANCE; GLP-1; SECRETION; GASTRIC BYPASS; GUT MICROBIOTA; INFLAMMATION; INGESTION; GHRELIN; LEPTIN;
D O I：
10.3389/fendo.2021.748477
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes
    Aschen, Seth Z.
    Zhang, Ashley
    O'Connell, Gillian M.
    Salingaros, Sophia
    Andy, Caroline
    Rohde, Christine H.
    Spector, Jason A.
    ANNALS OF SURGERY, 2025, 281 (04) : 600 - 607
  • [22] Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?
    Belancic, Andrej
    Kresovic, Andrea
    Troskot Dijan, Marija
    CLINICAL OBESITY, 2021, 11 (02)
  • [23] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [24] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [25] An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation
    Crossey, Caroline D.
    Garcia, Andrew
    Berenbrok, Lucas A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 1978 - 1979
  • [26] The Glucagon-Like Peptide-1 Receptor-or Not?
    Pyke, Charles
    Knudsen, Lotte Bjerre
    ENDOCRINOLOGY, 2013, 154 (01) : 4 - 8
  • [27] Role of glucagon-like peptide-1 receptor agonists in the treatment of obesity, cardiovascular disease, and cerebrovascular disease
    Tirandi, Amedeo
    Montecucco, Fabrizio
    Carbone, Federico
    Liberale, Luca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (02):
  • [28] Glucagon-like peptide-1 receptor agonists and safety in the preconception period
    Minis, Evelyn
    Stanford, Fatima Cody
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (06) : 273 - 279
  • [29] Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States
    Xu, Yunwen
    Tcheugui, Justin B. Echouffo
    Coresh, Josef
    Grams, Morgan E.
    Selvin, Elizabeth
    Fang, Michael
    Shin, Jung-Im
    DIABETES OBESITY & METABOLISM, 2025,
  • [30] The potential of glucagon-like peptide-1 receptor agonists in heart failure
    Kreiner, Frederik Flindt
    Hovingh, G. Kees Kornelis
    von Scholten, Bernt Johan
    FRONTIERS IN PHYSIOLOGY, 2022, 13
12345